Major response to imatinib mesylate in KIT-mutated melanoma

F. Stephen Hodi, Philip Friedlander, Christopher L. Corless, Michael C. Heinrich, Suzanne Mac Rae, Andrea Kruse, Jyothi Jagannathan, Annick D. Van Den Abbeele, Elsa F. Velazquez, George D. Demetri, David E. Fisher

Research output: Contribution to journalArticlepeer-review

360 Scopus citations

Fingerprint

Dive into the research topics of 'Major response to imatinib mesylate in KIT-mutated melanoma'. Together they form a unique fingerprint.